Assyro AI

Orange Book product · Generic (ANDA)

POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Generic (ANDA)ANDA 213523TE APRX FRESENIUS KABI USA

At a glance

Mar 09, 2021

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 09, 2021

    5 yr 4 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Strength

5GM/100ML;74.5MG/100ML;450MG/100ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 213523

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.